Start/MO

Public research page

Market data comes from the live feed. The company research below uses verified public sources, but it is not a real-time personalized AI conclusion.

Analyze MO in workspace
MONYSE/consumer staples

Altria Group, Inc.

$71.87Up+0,08 (+0,11%)
Research reviewed: 12. Juli 2026, 00:00 UTC
Research overview3-month price contextInvestment thesisKey catalystsLatest earnings researchRecent newsData and research sources

Research overview

Altria Group, Inc. operates in Tobacco within the consumer staples sector. This profile tracks its company-specific earnings drivers, valuation conditions, and primary-source risks.

Eröffnung
71,84
Hoch
73,02
Tief
71,59
Marktkapitalisierung
120,02 Mrd.
KGV
15.00
52-Wochen-Hoch
--
Dividende
5.910%
Quartalsdividende
--

3-month price context

Das Chart zeigt den jüngsten 3-Monats-Trend, damit Nutzer die kurzfristige Struktur verstehen können, bevor sie den vollen Workspace öffnen.

Investment thesis

Base case
Premium-brand pricing can partly offset secular cigarette volume decline. The base case remains conditional on cigarette decline staying manageable.
Bull case
Premium-brand pricing can partly offset secular cigarette volume decline. on! and on! PLUS can broaden Altria's smoke-free portfolio. Cash generation supports dividends and repurchases.
Bear case
Combustible volumes face persistent secular and affordability pressure. FDA actions, taxes and litigation can impair products and economics. Product authorization and market-return uncertainty constrain e-vapor progress.
Thesis invalidation
Reassess the thesis if combustible volumes face persistent secular and affordability pressure.

Key catalysts

  • Pricing power

    Premium-brand pricing can partly offset secular cigarette volume decline.

  • Oral nicotine

    on! and on! PLUS can broaden Altria's smoke-free portfolio.

  • Shareholder returns

    Cash generation supports dividends and repurchases.

Principal risks

  • Cigarette decline

    Combustible volumes face persistent secular and affordability pressure.

  • Nicotine regulation

    FDA actions, taxes and litigation can impair products and economics.

  • NJOY uncertainty

    Product authorization and market-return uncertainty constrain e-vapor progress.

Latest earnings research

Q1 2026

Altria reported a strong first quarter supported by smokeable-products income and oral nicotine growth while continuing investment in smoke-free products.

Valuation interpretation

  • Execution quality: The valuation case depends on pricing power translating into durable cash-flow growth.
  • Risk balance: Expected returns should be weighed against cigarette decline and capital requirements.

Peer research

PMCOSTKO

Recent news

24/7 Wall St. · vor 13 Stunden

The Market Could Crack This Summer: 5 Defensive High-Yielding Dividend Stocks to Buy Now

MarketBeat · vorgestern

This Dividend ETF Choice Could Shape Your Income Strategy Through 2026

Motley Fool · vorgestern

3 High-Yield Dividend Stocks Paying 5% or More That Are Worth Buying Now

Barrons.com · vor 3 Tagen

Why Verizon, Clorox and More Dividend Stocks Are Flashing a Buy Signal

24/7 Wall St. · vor 3 Tagen

Stock Of A Great Dividend King Jumps 24%

Continue in the research workspace

Keep MO in context, run a multi-agent analysis, and monitor thesis changes.

Analyze MO free

Das gesamte Research-System erkunden

Jede Phase erfüllt eine klare Aufgabe und hinterlässt ein prüfbares Ergebnis.

AnalysemethodikMarktberichte lesen

24/7 Wall St. · vor 4 Tagen

3 High-Yield Dividend Stocks to Buy in July

Data and research sources

Research updated: 12. Juli 2026, 00:00 UTC
3 verified sources
Altria Reports 2026 First-Quarter Results; Reaffirms Full-Year GuidanceAltria Group, Inc. · earningsVerified

Fetched: 12.7.2026, 0:00:00 UTC

Published: 30.4.2026, 00:00:00

Open original source
Altria Group, Inc. Investor RelationsAltria Group, Inc. · companyVerified

Fetched: 12.7.2026, 0:00:00 UTC

Open original source
Altria Group, Inc. SEC filings and company factsU.S. Securities and Exchange Commission · filingVerified

Fetched: 12.7.2026, 0:00:00 UTC

Published: 30.4.2026, 00:00:00

Open original source
Aktien erkunden

Continue researching this stock

Marktanalyst

Marktanalyst fokussiert sich innerhalb von Kernresearch auf die Phase Beobachten und bereitet den Kontext für nachgelagerte Rollen vor.

Fundamentalanalyst

Fundamentalanalyst fokussiert sich innerhalb von Kernresearch auf die Phase Beobachten und bereitet den Kontext für nachgelagerte Rollen vor.

Nachrichtenanalyst

Nachrichtenanalyst fokussiert sich innerhalb von Kernresearch auf die Phase Beobachten und bereitet den Kontext für nachgelagerte Rollen vor.

Risikomanager

Risikomanager fokussiert sich innerhalb von Risiko und Monitoring auf die Phase Überwachen und bereitet den Kontext für nachgelagerte Rollen vor.